Cytosolic sulfotransferase 1A3 is induced by dopamine and protects neuronal cells from dopamine toxicity: Role of D1 receptor-n-methyl-d-aspartate receptor coupling

Journal of Biological Chemistry

Volumn 288, Issue 48, 2013, Pages 34364-34374

  Sidharthan, Neelima P ^a   Minchin, Rodney F ^a   Butcher, Neville J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MONOAMINE OXIDASE; NEURON-LIKE CELLS; NEURONAL CELL; NEUROTOXICITY; NMDA RECEPTOR; O-METHYLTRANSFERASE; PHARMACOLOGICAL AGENTS; RISK FACTORS;

MAMMALS; METABOLISM; NEURODEGENERATIVE DISEASES; NEURONS; PHYSIOLOGY; TOXICITY;

AMINES;

CALCINEURIN; DOPAMINE; DOPAMINE 1 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SULFOTRANSFERASE; SULFOTRANSFERASE 1A1; SULFOTRANSFERASE 1A3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOPAMINE METABOLISM; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MOUSE; NERVE CELL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; UPREGULATION;

EID: 84889022838     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.493239     Document Type: Article

References (51)

1. Beaulieu, J. M., and Gainetdinov, R. R. (2011) The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol. Rev. 63, 182-217
2. Bromberg-Martin, E. S., Matsumoto, M., and Hikosaka, O. (2010) Dopamine in motivational control: rewarding, aversive, and alerting. Neuron 68, 815-834
3. Tayebati, S. K., Lokhandwala, M. F., and Amenta, F. (2011) Dopamine and vascular dynamics control: present status and future perspectives. Curr. Neurovasc. Res. 8, 246-257
4. Blum, K., Chen, A. L., Giordano, J., Borsten, J., Chen, T. J., Hauser, M., Simpatico, T., Femino, J., Braverman, E. R., and Barh, D. (2012) The addictive brain: all roads lead to dopamine. J. Psychoactive Drugs 44, 134-143
5. Ungless, M. A., and Grace, A. A. (2012) Are you or aren't you? Challenges associated with physiologically identifying dopamine neurons. Trends Neurosci. 35, 422-430
6. Wu, J., Xiao, H., Sun, H., Zou, L., and Zhu, L. Q. (2012) Role of dopamine receptors in ADHD: a systematic meta-analysis. Mol. Neurobiol. 45, 605-620
7. Chen, L., Ding, Y., Cagniard, B., Van Laar, A. D., Mortimer, A., Chi, W., Hastings, T. G., Kang, U. J., and Zhuang, X. (2008) Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice. J. Neurosci. 28, 425-433
8. Chen, J., Rusnak, M., Luedtke, R. R., and Sidhu, A. (2004) D1 dopamine receptor mediates dopamine-induced cytotoxicity via the ERK signal cascade. J. Biol. Chem. 279, 39317-39330
9. Lotharius, J., and Brundin, P. (2002) Pathogenesis of Parkinson's disease: dopamine, vesicles and α-synuclein. Nat. Rev. Neurosci. 3, 932-942
10. Avramovich-Tirosh, Y., Amit, T., Bar-Am, O., Zheng, H., Fridkin, M., and Youdim, M. B. (2007) Therapeutic targets and potential of the novel brainpermeable multifunctional iron chelator-monoamine oxidase inhibitor drug, M-30, for the treatment of Alzheimer's disease. J. Neurochem. 100, 490-502
11. Yan, M., Webster, L. T., Jr., and Blumer, J. L. (2002) Kinetic interactions of dopamine and dobutamine with human catechol-O-methyltransferase and monoamine oxidase in vitro. J. Pharmacol. Exp. Ther. 301, 315-321
12. Cedarbaum, J. M., and Olanow, C. W. (1991) Dopamine sulfate in ventricular cerebrospinal fluid and motor function in Parkinson's disease. Neurology 41, 1567-1570
13. Cappai, R., Leck, S. L., Tew, D. J., Williamson, N. A., Smith, D. P., Galatis, D., Sharples, R. A., Curtain, C. C., Ali, F. E., Cherny, R. A., Culvenor, J. G., Bottomley, S. P., Masters, C. L., Barnham, K. J., and Hill, A. F. (2005) Dopamine promotes α-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway. FASEB J. 19, 1377-1379
14. Sai, Y., Wu, Q., Le, W., Ye, F., Li, Y., and Dong, Z. (2008) Rotenoneinduced PC12 cell toxicity is caused by oxidative stress resulting from altered dopamine metabolism. Toxicol. in Vitro 22, 1461-1468
15. Kurogi, K., Alazizi, A., Liu, M. Y., Sakakibara, Y., Suiko, M., Sugahara, T., and Liu, M. C. (2012) Concerted actions of the catechol O-methyltransferase and the cytosolic sulfotransferase SULT1A3 in the metabolism of catecholic drugs. Biochem. Pharmacol. 84, 1186-1195
16. Zhu, X., Veronese, M. E., Bernard, C. C., Sansom, L. N., and McManus, M. E. (1993) Identification of two human brain aryl sulfotransferase cDNAs. Biochem. Biophys. Res. Commun. 195, 120-127
17. Thomae, B. A., Rifki, O. F., Theobald, M. A., Eckloff, B. W., Wieben, E. D., and Weinshilboum, R. M. (2003) Human catecholamine sulfotransferase (SULT1A3) pharmacogenetics: functional genetic polymorphism. J. Neurochem. 87, 809-819
18. Hildebrandt, M. A., Salavaggione, O. E., Martin, Y. N., Flynn, H. C., Jalal, S., Wieben, E. D., and Weinshilboum, R. M. (2004) Human SULT1A3 pharmacogenetics: gene duplication and functional genomic studies. Biochem. Biophys. Res. Commun. 321, 870-878
19. Riches, Z., Stanley, E. L., Bloomer, J. C., and Coughtrie, M. W. (2009) Quantitative evaluation of the expression and activity of five major sulfotransferases (SULTs) in human tissues: the SULT "pie." Drug Metab. Dispos. 37, 2255-2261
20. Dajani, R., Cleasby, A., Neu, M., Wonacott, A. J., Jhoti, H., Hood, A. M., Modi, S., Hersey, A., Taskinen, J., Cooke, R. M., Manchee, G. R., and Coughtrie, M. W. (1999) X-ray crystal structure of human dopamine sulfotransferase, SULT1A3: molecular modeling and quantitative structure- activity relationship analysis demonstrate a molecular basis for sulfotransferase substrate specificity. J. Biol. Chem. 274, 37862-37868
21. Dajani, R., Hood, A. M., and Coughtrie, M. W. (1998) A single amino acid, Glu-146, governs the substrate specificity of a human dopamine sulfotransferase, SULT1A3. Mol. Pharmacol. 54, 942-948
22. Gamage, N., Barnett, A., Hempel, N., Duggleby, R. G., Windmill, K. F., Martin, J. L., and McManus, M. E. (2006) Human sulfotransferases and their role in chemical metabolism. Toxicol. Sci. 90, 5-22
23. Goldstein, D. S., Swoboda, K. J., Miles, J. M., Coppack, S. W., Aneman, A., Holmes, C., Lamensdorf, I., and Eisenhofer, G. (1999) Sources and physiological significance of plasma dopamine sulfate. J. Clin. Endocrinol. Metab. 84, 2523-2531
24. Salman, E. D., Kadlubar, S. A., and Falany, C. N. (2009) Expression and localization of cytosolic sulfotransferase (SULT) 1A1 and SULT1A3 in normal human brain. Drug Metab. Dispos. 37, 706-709
25. Thiel, G., Al Sarraj, J., Vinson, C., Stefano, L., and Bach, K. (2005) Role of basic region leucine zipper transcription factors cyclic AMP response element- binding protein (CREB), CREB2, activating transcription factor 2 and CAAT/enhancer-binding protein α in cyclic AMP response elementmediated transcription. J. Neurochem. 92, 321-336
26. Richard, K., Hume, R., Kaptein, E., Stanley, E. L., Visser, T. J., and Coughtrie, M. W. (2001) Sulfation of thyroid hormone and dopamine during human development: ontogeny of phenol sulfotransferases and arylsulfatase in liver, lung, and brain. J. Clin. Endocrinol. Metab. 86, 2734-2742
27. Jassen, A. K., Yang, H., Miller, G. M., Calder, E., and Madras, B. K. (2006) Receptor regulation of gene expression of axon guidance molecules: implications for adaptation. Mol. Pharmacol. 70, 71-77
28. Lee, F. J., Xue, S., Pei, L., Vukusic, B., Chéry, N., Wang, Y., Wang, Y. T., Niznik, H. B., Yu, X. M., and Liu, F. (2002) Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor. Cell 111, 219-230
29. Fiorentini, C., Gardoni, F., Spano, P., Di Luca, M., and Missale, C. (2003) Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-D-aspartate receptors. J. Biol. Chem. 278, 20196-20202
30. Hallett, P. J., Spoelgen, R., Hyman, B. T., Standaert, D. G., and Dunah, A. W. (2006) Dopamine D1 activation potentiates striatal NMDA receptors by tyrosine phosphorylation-dependent subunit trafficking. J. Neurosci. 26, 4690-4700
31. Snyder, G. L., Fienberg, A. A., Huganir, R. L., and Greengard, P. (1998) A dopamine/D1 receptor/protein kinase A/dopamine- and cAMP-regulated phosphoprotein (Mr 32 kDa)/protein phosphatase-1 pathway regulates dephosphorylation of the NMDA receptor. J. Neurosci. 18, 10297-10303
32. Chen, G., Greengard, P., and Yan, Z. (2004) Potentiation ofNMDAreceptor currents by dopamine D1 receptors in prefrontal cortex. Proc. Natl. Acad. Sci. U.S.A. 101, 2596-2600
33. Valjent, E., Pascoli, V., Svenningsson, P., Paul, S., Enslen, H., Corvol, J. C., Stipanovich, A., Caboche, J., Lombroso, P. J., Nairn, A. C., Greengard, P., Hervé, D., and Girault, J. A. (2005) Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc. Natl. Acad. Sci. U.S.A. 102, 491-496
34. Kaphzan, H., O'Riordan, K. J., Mangan, K. P., Levenson, J. M., and Rosenblum, K. (2006) NMDA and dopamine converge on the NMDA-receptor to induce ERK activation and synaptic depression in mature hippocampus. PLoS One 1, e138
35. Marshall, J., Dolan, B. M., Garcia, E. P., Sathe, S., Tang, X., Mao, Z., and Blair, L. A. (2003) Calcium channel and NMDA receptor activities differentially regulate nuclear C/EBPα levels to control neuronal survival. Neuron 39, 625-639
36. Li, H., Rao, A., and Hogan, P. G. (2011) Interaction of calcineurin with substrates and targeting proteins. Trends Cell Biol. 21, 91-103
37. Rusnak, F., and Mertz, P. (2000) Calcineurin: form and function. Physiol. Rev. 80, 1483-1521
38. Hempel, N., Wang, H., LeCluyse, E. L., McManus, M. E., and Negishi, M. (2004) The human sulfotransferase SULT1A1 gene is regulated in a synergistic manner by Sp1 and GA binding protein. Mol. Pharmacol. 66, 1690-1701
39. Angus, L. M., Chakkalakal, J. V., Méjat, A., Eibl, J. K., Bélanger, G., Megeney, L. A., Chin, E. R., Schaeffer, L., Michel, R. N., and Jasmin, B. J. (2005) Calcineurin-NFAT signaling, together with GABP and peroxisome PGC-1α, drives utrophin gene expression at the neuromuscular junction. Am. J. Physiol. Cell Physiol. 289, C908-917
40. Butcher, N. J., Mitchell, D. J., Burow, R., and Minchin, R. F. (2010) Regulation of mouse brain-selective sulfotransferase sult4a1 by cAMP response element-binding protein and activating transcription factor-2. Mol. Pharmacol. 78, 503-510
41. Mayr, B., and Montminy, M. (2001) Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell Biol. 2, 599-609
42. Jeon, S. M., Cheon, S. M., Bae, H. R., Kim, J. W., and Kim, S. U. (2010) Selective susceptibility of human dopaminergic neural stem cells to dopamine- induced apoptosis. Exp. Neurobiol. 19, 155-164
43. Lev, N., Ickowicz, D., Barhum, Y., Lev, S., Melamed, E., and Offen, D. (2009) DJ-1 protects against dopamine toxicity. J. Neural Transm. 116, 151-160
44. Gandhi, S., Vaarmann, A., Yao, Z., Duchen, M. R., Wood, N. W., and Abramov, A. Y. (2012) Dopamine-induced neurodegeneration in a PINK1 model of Parkinson's disease. PLoS One 7, e37564
45. Ziv, I., Melamed, E., Nardi, N., Luria, D., Achiron, A., Offen, D., and Barzilai, A. (1994) Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons: a possible novel pathogenetic mechanism in Parkinson's disease. Neurosci. Lett. 170, 136-140
46. Lawrence, M. C., McGlynn, K., Park, B. H., and Cobb, M. H. (2005) ERK1/ 2-dependent activation of transcription factors required for acute and chronic effects of glucose on the insulin gene promoter. J. Biol. Chem. 280, 26751-26759
47. Sanna, B., Bueno, O. F., Dai, Y. S., Wilkins, B. J., and Molkentin, J. D. (2005) Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth. Mol. Cell. Biol. 25, 865- 878
48. Li, X., Zhu, L., Yang, A., Lin, J., Tang, F., Jin, S., Wei, Z., Li, J., and Jin, Y. (2011) Calcineurin-NFAT signaling critically regulates early lineage specification in mouse embryonic stem cells and embryos. Cell Stem Cell 8, 46-58
49. Oh, M., Dey, A., Gerard, R. D., Hill, J. A., and Rothermel, B. A. (2010) The CCAAT/enhancer binding protein β(C/EBPα) cooperates with NFAT to control expression of the calcineurin regulatory proteinRCAN1-4. J. Biol. Chem. 285, 16623-16631
50. Handschin, C., and Meyer, U. A. (2003) Induction of drug metabolism: the role of nuclear receptors. Pharmacol. Rev. 55, 649-673
51. Xu, C., Li, C. Y., and Kong, A. N. (2005) Induction of phase I, II, and III drug metabolism/transport by xenobiotics. Arch. Pharm. Res. 28, 249-268